ImmunoGen Raises $84M, Cablevision Founder Backs Crimson Hexagon, BzzAgent Bought, & More Boston-Area Deals News
(Page 2 of 2)
an unnamed oil driller. The startup is working on a battery made of liquid anode, cathode, and electrolyte components, to better store wind and solar energy.
—Cambridge, MA-based osteoporosis drug maker Radius Health said it raised $91 million in a third financing round, which includes $66 million in equity. It also merged with an unlisted shell company (“MAC”), so that it can take on the status of an SEC-reporting company and apply to be listed on a national stock exchange. The financing will go to completing pivotal Phase 3 clinical trials of its novel bone-building drug.
—Harvest Power, a Waltham, MA-based cleantech and waste management company, bumped its Series B funding up to $57.7 million, with a fresh $6 million tranche this week. The new money comes from SAM Private Equity.
—Casenet. a healthcare software developer of Bedford, MA, added $3.3 million in financing and bumped its funding round target up from $8.8 million up to $15.8 million.
—QD Vision and Crimson Hexagon each announced fundings yesterday. Watertown, MA-based QD, a developer of nanomaterials for displays and lighting applications, took in $22 million from new and existing investors. And Cambridge-based social media monitoring and analysis startup Crimson grabbed $5 million in Series B money from Charles Dolan, the founder and chairman of Cablevision Systems (NYSE: CVC).